Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Current Assets (2009 - 2026)

Compugen (CGEN) posted quarterly Current Assets of $137.3 million for Q1 2026, up 28.43% year-over-year from $106.9 million in Q1 2025, and down 7.25% on a QoQ basis from $148.0 million in Q4 2025.

Analysis

Compugen (CGEN) Current Assets (2009 - 2026) Analysis & Trends

Compugen has reported Current Assets for 18 years, with the latest figure at $137.3 million in Q1 2026.

  • Current Assets for Q1 2026 came in at $137.3 million, up 28.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $137.3 million (up 28.43% YoY), and the FY2025 annual result was $148.0 million, up 39.65% from the prior year.
  • Current Assets slipped to $137.3 million in Q1 2026, from $148.0 million in the prior quarter.
  • Over five years, Current Assets peaked at $148.0 million in Q4 2025 and troughed at $60.3 million in Q3 2023.
  • A 5-year average of $101.1 million and a median of $102.1 million in 2024 frame the typical range for Current Assets.
  • The widest annual swing landed in 2023, when Current Assets sank 33.8%; it then soared 90.52% in 2024.
  • A 5-year view of Current Assets shows it stood at $86.1 million in 2022, then jumped by 33.04% to $114.6 million in 2023, then fell by 7.49% to $106.0 million in 2024, then soared by 39.65% to $148.0 million in 2025, then declined by 7.25% to $137.3 million in 2026.
  • Per Business Quant data, the three most recent Current Assets figures were $137.3 million in Q1 2026, $148.0 million in Q4 2025, and $88.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 129.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.41 Mn
Mar 31, 2026 137.28 Mn
Dec 31, 2025 148.02 Mn
Sep 30, 2025 88.92 Mn
Jun 30, 2025 97.64 Mn
Mar 31, 2025 106.89 Mn
Dec 31, 2024 106.00 Mn
Sep 30, 2024 114.83 Mn
Jun 30, 2024 102.13 Mn
Mar 31, 2024 105.57 Mn
Dec 31, 2023 114.58 Mn
Sep 30, 2023 60.27 Mn
Jun 30, 2023 69.40 Mn
Mar 31, 2023 76.44 Mn
Dec 31, 2022 86.13 Mn
Sep 30, 2022 91.04 Mn
Jun 30, 2022 101.98 Mn
Mar 31, 2022 112.12 Mn
Dec 31, 2021 123.22 Mn
Sep 30, 2021 112.28 Mn